The following table, which is based on data from the Star*D trial conducted by the National Institute of Mental Health in 2006, indicates the worldwide estimated patient populations suffering with new onset MDD, persistent MDD and TRD, and the primary treatment options available. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of Each Class Trading Symbol Name of each exchange on which registered American Depositary Shares, each representing one ordinary share, par value of £0. ...

There are some great microcap stocks for investors to scoop up this month. The broader indices, such as the S&P 500 and the Nasdaq, are showing signs of both strength and weakness, but I believe that there’s still a lot of gas left in the tank for these to surge higher.In this environment, astute investors are turning their attention to the often-overlooked microcap sector, where promising companies with innovative products, strong management teams and compelling growth prospects reside. Despite their small ...

LONDON, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a panel discussion at the TD Cowen 44th Annual Health Care Conference at 12:50 pm ET on March 4, 2024. A live audio webcast of the panel discussion will be accessible from the "Events" page of the Investors section of the Compass website. A replay of the webcast will be ...

LONDON, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a panel discussion at the TD Cowen 44th Annual Health Care Conference at 12:50 pm ET on March 4, 2024. A live audio webcast of the panel discussion will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will b ...

LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the Oppenheimer 34th Annual Healthcare Life Sciences Conference at 2:00 pm ET on February 13, 2024. A live audio webcast of the fireside chat will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast wil ...

LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the Oppenheimer 34th Annual Healthcare Life Sciences Conference at 2:00 pm ET on February 13, 2024. A live audio webcast of the fireside chat will be accessible from the "Events" page of the Investors section of the Compass website. A replay of the webcast will ...

COMPASS Pathways plc (NASDAQ:CMPS) Q3 2023 Results Conference Call November 2, 2023 8:00 AM ET Company Participants Stephen Schultz - SVP, IR Kabir Nath - CEO Mary-Rose Hughes - Interim CFO Dr. Guy Goodwin - Chief Medical Officer Conference Call Participants Ritu Baral - TD Cohen Charles Duncan - Cantor François Brisebois - Oppenheimer Patrick Trucchio - H.C. Wainright Michael Okunewitch - Maxim Group Sumant Kulkarni - Canaccord Genuity Gavin Clark-Gartner - Evercore ISI Thomas Shrader - BTIG Operator Good ...

Table of Contents • adding new clinical trial sites; • availability of adequately trained therapists and appropriate third-party clinical trial sites for the administration of COMP360 psilocybin treatment in our Phase 3 program and other clinical trials, including preparation, psilocybin administration and integration of the therapeutic experience; • sufficiency of any supporting digital services that may form part of the preparation, integration or long-term follow-up relating to any drug we develop; • fai ...

COMPASS Pathways plc (NASDAQ:CMPS) Q2 2023 Earnings Conference Call August 3, 2023 8:00 AM ET Company Participants Stephen Schultz - Senior Vice President of Investor Relations Kabir Nath - Chief Executive Officer Guy Goodwin - Chief Medical Officer Mike Falvey - Chief Financial Officer Conference Call Participants Ritu Baral - Cowen and Company, LLC Charles Duncan - Cantor Fitzgerald Patrick Trucchio - H.C. Wainwright & Co, LLC Francois Brisebois - Oppenheimer & Co. Elemer Piros - EF Hutton Thomas Shrader ...

• an increase of $0.8 million in non-cash share-based compensation expense due to increased staffing levels year over year and equity awards granted to our chief executive officer in August 2022; and During the six months ended June 30, 2023 and 2022, we recognized an R&D tax credit in the UK as a benefit within other income, net of $6.4 million and $7.0 million, respectively. The tax credit receivable decreased by $0.6 million in 2023 compared to 2022 due to a reduction in the R&D tax relief rates. Up unti ...